Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
54,26 USD | +1,89 % | +5,34 % | +5,92 % |
Kurzporträt
Die Vereinigten Staaten machen 70,1% des Nettoumsatzes aus.
Mitarbeiterzahl: 34 100
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 46 159 | 100,0 % | 45 006 | 100,0 % | -2,50 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
70,1
%
| 31 828 | 69,0 % | 31 555 | 70,1 % | -0,86 % |
International
28,3
%
| 13 497 | 29,2 % | 12 752 | 28,3 % | -5,52 % |
Other
1,6
%
| 834 | 1,8 % | 699 | 1,6 % | -16,19 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 53 | 01.02.15 | |
Giovanni Caforio
CHM | Chairman | 59 | 01.01.00 |
David Elkins
DFI | Director of Finance/CFO | 55 | 20.11.19 |
Samit Hirawat
CTO | Chief Tech/Sci/R&D Officer | 55 | 01.01.19 |
Robert Plenge
CTO | Chief Tech/Sci/R&D Officer | 53 | 01.11.19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 01.01.03 | |
Chief Tech/Sci/R&D Officer | - | - | |
Laura Hortas
IRO | Public Communications Contact | - | - |
Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 20.11.19 |
Peter Arduini
BRD | Director/Board Member | 59 | 01.04.16 |
Derica Rice
BRD | Director/Board Member | 59 | 01.09.20 |
Paula Price
BRD | Director/Board Member | 62 | 01.09.20 |
Theodore Samuels
BRD | Director/Board Member | 69 | 21.02.17 |
David Elkins
DFI | Director of Finance/CFO | 55 | 20.11.19 |
Chief Executive Officer | 53 | 01.02.15 | |
Giovanni Caforio
CHM | Chairman | 59 | 01.01.00 |
Julia Haller
BRD | Director/Board Member | 69 | 20.11.19 |
Karen Vousden
BRD | Director/Board Member | 66 | 01.01.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 2 924 193 411 | 2 020 069 789 ( 69,08 %) | 902 000 000 ( 30,85 %) | 69,08 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
5 075 304 | 6,85% | 92 878 063 $ | |
KURA ONCOLOGY, INC. 1,80% | 1 370 171 | 1,80% | 28 883 205 $ |
70 231 140 | 17,02% | 19 287 578 $ | |
UNIQURE N.V. 4,99% | 2 388 108 | 4,99% | 13 731 621 $ |
COMPUGEN LTD. 5,39% | 4 757 058 | 5,39% | 12 273 210 $ |
CELULARITY INC. 5,49% | 1 195 327 | 5,49% | 4 279 271 $ |
Unternehmenskontakt
Bristol Myers Squibb Co.
Route 206 & Province Line Road
08543, Princeton
+609 252 4621
http://www.bms.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. |
Pharmaceuticals: Major
|
Celgene Alpine Investment Co. LLC
| |
Bristol-Myers Squibb SARL
Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. |
Medical Distributors
|
Bristol-Myers Squibb Holdings Ireland Unlimited Co.
Bristol-Myers Squibb Holdings Ireland Unlimited Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Holdings Ireland Unlimited Co., a subsidiary of Bristol Myers Squibb Co., is a company headquartered in Ireland that operates as a holding company which develops medicines for serious diseases. |
Pharmaceuticals: Major
|
Bristol-Myers Squibb Australia Pty Ltd.
Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Australia Pty Ltd. is a biopharmaceutical company that researches, develops and markets medicines for serious diseases. The company was founded in 1930 and is headquartered in Noble Park North, Australia. |
Pharmaceuticals: Major
|
Bristol-Myers Squibb (Finland) Oy Ab
Bristol-Myers Squibb (Finland) Oy Ab Pharmaceuticals: GenericHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb (Finland) Oy Ab is a Finnish pharmaceutical manufacturing company. The private company is based in Vantaa, Finland. The company was founded in 1974. Simone Böhrer has been the CEO of the company since 2020. |
Pharmaceuticals: Generic
|
Bristol-Myers Squibb Belgium SA
Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The private company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. |
Pharmaceuticals: Major
|
Bristol-Myers Squibb de México S de RL de CV
Bristol-Myers Squibb de México S de RL de CV Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb de México S de RL de CV is a Mexican company that manufactures and supplies pharmaceutical and nutritional products. The private company is located in Mexico. |
Pharmaceuticals: Major
|
Bristol-Myers Squibb AB
Bristol-Myers Squibb AB Medical DistributorsDistribution Services Part of Bristol Myers Squibb Co., Bristol-Myers Squibb AB is a private company that wholesales medical equipment and pharmacy. The company is based in Solna, Sweden. |
Medical Distributors
|
Sektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+5,92 % | 108 Mrd. | |
+34,15 % | 701 Mrd. | |
+26,24 % | 571 Mrd. | |
+1,10 % | 381 Mrd. | |
+20,80 % | 334 Mrd. | |
+17,11 % | 319 Mrd. | |
+0,74 % | 210 Mrd. | |
+2,95 % | 210 Mrd. | |
-6,05 % | 201 Mrd. | |
-2,59 % | 157 Mrd. |
- Börse
- Aktien
- Aktie Bristol-Myers Squibb Company - Nyse
- Unternehmen Bristol-Myers Squibb Company